KRAS and sarcoma: Biallelic inactivation of TP53 is the most common co-occurring event seen in DICER1-mutant sarcomas, and genetic alterations in NF1, KRAS, NRAS, FGFR4, EGFR, and PDGFRA have also been reported5,10–14.